Economic Evaluation of Newborn Hearing Screening: Modelling Costs and Outcomes

DSpace/Manakin Repository

Economic Evaluation of Newborn Hearing Screening: Modelling Costs and Outcomes

Citable link to this page


Title: Economic Evaluation of Newborn Hearing Screening: Modelling Costs and Outcomes
Author: Hessel, Franz; Grill, Eva; Schnell-Inderst, Petra; Kunze, Silke; Nickisch, Andreas; von Voß, Hubertus; Wasem, Jürgen; Siebert, Uwe

Note: Order does not necessarily reflect citation order of authors.

Citation: Hessel, Franz, Eva Grill, Petra Schnell-Inderst, Uwe Siebert, Silke Kunze, Andreas Nickisch, Hubertus von Voß, and Jürgen Wasem. 2003. Economic evaluation of newborn hearing screening: modelling costs and outcomes. German Medical Science 1: GMS e-journal 1.
Full Text & Related Files:
Abstract: Objectives: The prevalence of newborn hearing disorders is 1-3 per 1,000. Crucial for later outcome are correct diagnosis and effective treatment as soon as possible. With BERA and TEOAE low-risk techniques for early detection are available. Universal screening is recommended but not realised in most European health care systems. Aim of the study was to examine the scientific evidence of newborn hearing screening and a comparison of medical outcome and costs of different programmes, differentiated by type of strategy (risk screening, universal screening, no systematical screening). Methods: In an interdisciplinary health technology assessment project all studies on newborn hearing screening detected in a standardized comprehensive literature search were identified and data on medical outcome, costs, and cost-effectiveness extracted. A Markov model was designed to calculate cost-effectiveness ratios. Results: Economic data were extracted from 20 relevant publications out of 39 publications found. In the model total costs for screening of 100,000 newborns with a time horizon of ten years were calculated: 2.0 Mio.€ for universal screening (U), 1.0 Mio.€ for risk screening (R), and 0.6 Mio.€ for no screening (N). The costs per child detected: 13,395€ (U) respectively 6,715€ (R), and 4,125€ (N). At 6 months of life the following percentages of cases are detected: U 72%, R 43%, N 13%. Conclusions: A remarkable small number of economic publications mainly of low methodological quality was found. In our own model we found reasonable cost-effectiveness ratios also for universal screening. Considering the outcome advantages of higher numbers of detected cases a universal newborn hearing screening is recommended.
Published Version:
Other Sources:
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at
Citable link to this page:
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)


Search DASH

Advanced Search